Literature DB >> 27921263

Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.

Chunsun Li1, Miaomiao Wu2, Guijuan Zong1, Chunhua Wan3, Qingqing Liu2, Huiling Zhou4, Lu Hua5, Yuyan Chen6, Xudong Chen7, Cuihua Lu8.   

Abstract

BACKGROUND: Protein phosphatase 1γ (PP1γ), as a member of the protein phosphatase 1 family, may be involved in regulation of multiple cellular processes, such as mitosis, cell survival, and apoptosis. However, little is known about the underlying mechanisms by which PP1γ regulates hepatocellular carcinoma development. AIM: We investigated the expression profile of PP1γ in hepatocellular carcinoma (HCC) cell lines and human HCC specimens, as well as its potential prognostic significance in HCC.
METHODS: PP1γ expression profile was detected in 94 HCC specimens using immunohistochemistry. PP1γ levels in HCC cells were downregulated by small interfering RNA (siRNA) transfection. Cell cycle progression and proliferation status of HCC cells and the effectiveness of doxorubicin were evaluated by flow cytometry and CCK-8 assay. The levels of PP1γ, CyclinD1, PCNA, Mdmx, p53, p21, and active caspase-3 were evaluated by Western blot analysis.
RESULTS: PP1γ was upregulated in tumorous specimens, compared with adjacent nontumorous tissues. Univariate and multivariate survival analyses were conducted to determine the prognostic significance of PP1γ in HCC. The expression pattern of PP1γ was positively correlated with tumor size, histological grade, Ki-67 expression, and poor prognosis in HCC. In addition, depletion of PP1γ by siRNA could inhibit cell proliferation, resulted in G1 phase arrest, and attenuated resistance to doxorubicin in Huh7 cells.
CONCLUSIONS: PP1γ is upregulated in HCC cell lines and HCC specimens, promotes cancer cell proliferation through regulation of p53, and may be a potential target for treatment of HCC.

Entities:  

Keywords:  Doxorubicin resistance; Hepatocellular carcinoma; PP1γ; Proliferation

Mesh:

Substances:

Year:  2016        PMID: 27921263     DOI: 10.1007/s10620-016-4365-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  24 in total

1.  MIF4G domain containing protein regulates cell cycle and hepatic carcinogenesis by antagonizing CDK2-dependent p27 stability.

Authors:  C Wan; S Hou; R Ni; L Lv; Z Ding; X Huang; Q Hang; S He; Y Wang; C Cheng; X X Gu; G Xu; A Shen
Journal:  Oncogene       Date:  2013-12-16       Impact factor: 9.867

2.  Regulation of protein phosphatase 1gamma activity in hypoxia through increased interaction with NIPP1: implications for cellular metabolism.

Authors:  Kathrina M Comerford; Martin O Leonard; Eoin P Cummins; Kathleen T Fitzgerald; Monique Beullens; Mathieu Bollen; Cormac T Taylor
Journal:  J Cell Physiol       Date:  2006-10       Impact factor: 6.384

3.  Regulation of Raf-1 activation and signalling by dephosphorylation.

Authors:  Amardeep S Dhillon; Sharon Meikle; Zihni Yazici; Manfred Eulitz; Walter Kolch
Journal:  EMBO J       Date:  2002-01-15       Impact factor: 11.598

4.  URI is an oncogene amplified in ovarian cancer cells and is required for their survival.

Authors:  Jean-Philippe Theurillat; Stefan Christian Metzler; Nico Henzi; Nabil Djouder; Marianne Helbling; Anna-Kathrin Zimmermann; Francis Jacob; Alex Soltermann; Rosmarie Caduff; Viola Heinzelmann-Schwarz; Holger Moch; Wilhelm Krek
Journal:  Cancer Cell       Date:  2011-03-08       Impact factor: 31.743

Review 5.  Current management strategy of hepatocellular carcinoma.

Authors:  Bernardino Rampone; Beniamino Schiavone; Antonio Martino; Carmine Viviano; Giuseppe Confuorto
Journal:  World J Gastroenterol       Date:  2009-07-14       Impact factor: 5.742

Review 6.  Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma.

Authors:  Jordi Bruix; Maria Reig; Morris Sherman
Journal:  Gastroenterology       Date:  2016-01-12       Impact factor: 22.682

7.  Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21.

Authors:  Y Li; C W Jenkins; M A Nichols; Y Xiong
Journal:  Oncogene       Date:  1994-08       Impact factor: 9.867

Review 8.  Protein phosphatase 1--targeted in many directions.

Authors:  Patricia T W Cohen
Journal:  J Cell Sci       Date:  2002-01-15       Impact factor: 5.285

9.  The interaction of PP1 with BRCA1 and analysis of their expression in breast tumors.

Authors:  Sherry L Winter; Lucine Bosnoyan-Collins; Dushanthi Pinnaduwage; Irene L Andrulis
Journal:  BMC Cancer       Date:  2007-05-19       Impact factor: 4.430

10.  Repo-Man recruits PP1 gamma to chromatin and is essential for cell viability.

Authors:  Laura Trinkle-Mulcahy; Jens Andersen; Yun Wah Lam; Greg Moorhead; Matthias Mann; Angus I Lamond
Journal:  J Cell Biol       Date:  2006-02-21       Impact factor: 10.539

View more
  1 in total

1.  Kanglaite reverses multidrug resistance of HCC by inducing apoptosis and cell cycle arrest via PI3K/AKT pathway.

Authors:  Chendong Yang; Aihua Hou; Chunfeng Yu; Lingling Dai; Wen Wang; Kangle Zhang; Hongmin Shao; Jinghua Ma; Wenjuan Xu
Journal:  Onco Targets Ther       Date:  2018-02-26       Impact factor: 4.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.